PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Trinity Biotech plc (TRIB)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US8964383066

CUSIP

896438306

Sector

Healthcare

IPO Date

Aug 18, 1995

Highlights

Market Cap

$23.30M

EPS (TTM)

-$2.25

PEG Ratio

1.30

Total Revenue (TTM)

$59.13M

Gross Profit (TTM)

$20.14M

EBITDA (TTM)

-$6.43M

Year Range

$0.75 - $3.55

Target Price

$3.00

Short %

2.43%

Short Ratio

0.43

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
TRIB vs. MSFRX TRIB vs. CEG
Popular comparisons:
TRIB vs. MSFRX TRIB vs. CEG

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Trinity Biotech plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%200.00%400.00%600.00%800.00%1,000.00%JulyAugustSeptemberOctoberNovemberDecember
-98.16%
960.58%
TRIB (Trinity Biotech plc)
Benchmark (^GSPC)

Returns By Period

Trinity Biotech plc had a return of -62.70% year-to-date (YTD) and -60.49% in the last 12 months. Over the past 10 years, Trinity Biotech plc had an annualized return of -37.27%, while the S&P 500 had an annualized return of 11.06%, indicating that Trinity Biotech plc did not perform as well as the benchmark.


TRIB

YTD

-62.70%

1M

-38.46%

6M

-67.74%

1Y

-60.49%

5Y*

-31.02%

10Y*

-37.27%

^GSPC (Benchmark)

YTD

24.34%

1M

0.23%

6M

8.53%

1Y

24.95%

5Y*

13.01%

10Y*

11.06%

Monthly Returns

The table below presents the monthly returns of TRIB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202437.53%-26.10%-6.42%-10.78%-9.34%29.09%39.91%-33.22%-44.72%60.00%-37.50%-62.70%
20238.59%-1.86%-10.90%12.21%-11.83%2.27%-0.12%-15.79%-8.11%-37.15%3.25%-10.06%-56.67%
2022-19.58%-11.30%3.92%12.26%19.33%-13.73%11.02%-10.29%-12.21%8.31%14.66%-25.56%-30.77%
202125.20%12.37%-29.85%-8.51%-9.01%-6.07%-25.51%19.18%-17.24%-4.63%-10.19%-22.70%-62.47%
202021.93%13.49%-23.08%44.55%-20.75%73.02%14.22%-22.49%4.66%34.65%75.37%-20.13%268.69%
201917.90%12.59%-6.25%-5.96%-19.78%-23.26%33.33%-38.18%-11.03%-36.38%31.20%2.32%-54.87%
20188.63%-1.44%-5.68%-10.49%0.87%7.53%-6.40%-16.67%2.56%-25.75%-1.01%-22.11%-55.10%
2017-3.47%-7.63%-3.40%-4.53%-1.05%6.57%1.17%-11.37%4.28%-10.16%-2.78%4.08%-26.30%
2016-9.95%-7.37%18.86%-1.37%0.52%-1.90%13.14%4.60%-1.49%-48.41%-1.91%3.44%-41.16%
20155.88%-4.21%8.39%-12.88%3.16%5.69%-4.49%-10.96%-25.52%-1.84%6.68%-1.84%-32.00%
20143.26%2.04%-8.53%1.16%-2.12%-3.10%0.87%-6.11%-16.23%-4.76%-1.38%2.04%-29.70%
201311.86%4.84%-0.18%-5.27%9.63%-2.74%15.61%-2.31%14.35%14.89%2.52%-1.91%76.41%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of TRIB is 12, meaning it’s performing worse than 88% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of TRIB is 1212
Overall Rank
The Sharpe Ratio Rank of TRIB is 1616
Sharpe Ratio Rank
The Sortino Ratio Rank of TRIB is 1414
Sortino Ratio Rank
The Omega Ratio Rank of TRIB is 1717
Omega Ratio Rank
The Calmar Ratio Rank of TRIB is 1010
Calmar Ratio Rank
The Martin Ratio Rank of TRIB is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Trinity Biotech plc (TRIB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for TRIB, currently valued at -0.64, compared to the broader market-4.00-2.000.002.00-0.642.10
The chart of Sortino ratio for TRIB, currently valued at -0.90, compared to the broader market-4.00-2.000.002.004.00-0.902.80
The chart of Omega ratio for TRIB, currently valued at 0.90, compared to the broader market0.501.001.502.000.901.39
The chart of Calmar ratio for TRIB, currently valued at -0.68, compared to the broader market0.002.004.006.00-0.683.09
The chart of Martin ratio for TRIB, currently valued at -1.63, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.6313.49
TRIB
^GSPC

The current Trinity Biotech plc Sharpe ratio is -0.64. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Trinity Biotech plc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.64
2.10
TRIB (Trinity Biotech plc)
Benchmark (^GSPC)

Dividends

Dividend History

Trinity Biotech plc provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%0.50%1.00%1.50%2.00%$0.00$0.20$0.40$0.60$0.80$1.0020132014201520162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM20232022202120202019201820172016201520142013
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.10$1.10$1.00

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.87%1.26%0.80%

Monthly Dividends

The table displays the monthly dividend distributions for Trinity Biotech plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2015$0.00$0.00$0.00$0.00$0.00$1.10$0.00$0.00$0.00$0.00$0.00$0.00$1.10
2014$0.00$0.00$0.00$0.00$0.00$1.10$0.00$0.00$0.00$0.00$0.00$0.00$1.10
2013$1.00$0.00$0.00$0.00$0.00$0.00$0.00$1.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-99.41%
-2.62%
TRIB (Trinity Biotech plc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Trinity Biotech plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Trinity Biotech plc was 99.44%, occurring on Dec 19, 2024. The portfolio has not yet recovered.

The current Trinity Biotech plc drawdown is 99.41%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.44%Jan 17, 20142750Dec 19, 2024
-96.47%Mar 9, 20002261Mar 6, 20091225Jan 16, 20143486
-85.29%May 7, 1996612Oct 7, 1998357Mar 8, 2000969
-30.3%Dec 28, 199550Mar 8, 199637May 1, 199687
-19.48%Aug 24, 199581Dec 18, 19953Dec 21, 199584

Volatility

Volatility Chart

The current Trinity Biotech plc volatility is 22.46%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
22.46%
3.79%
TRIB (Trinity Biotech plc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Trinity Biotech plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Trinity Biotech plc.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab